SCHEMBL6838548

SCHEMBL6838548

Cc1ccc2c(c1)nc(C(F)(F)F)c1nc(-c3ccco3)n(CCC3CNCCO3)c12

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.32
SLC6A4 P31645 11/20 0.32
SLC6A3 Q01959 6/20 0.32
ALDH1A1 P00352 5/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HBB P68871 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP2D6 P10635 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838620 0.92 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL6838542 0.91 PIK3R1 (0.33) SLC6A2SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL6837682 0.89 GRIN1 (0.35) SLC6A2SLC6A4SLC6A3CYP2D6CYP3A4
SCHEMBL6838074 0.87 ALDH1A1 (0.33) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL6837757 0.86 SSTR4 (0.38) SLC6A2SLC6A4SLC6A3ALDH1A1SMN1; SMN2
SCHEMBL6838398 0.86 SLC6A2 (0.32) SLC6A2SLC6A4SLC6A3CYP2D6HRH1
SCHEMBL6838104 0.85 MAPT (0.34) SLC6A2SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL6840135 0.83 JAK1 (0.31) SLC6A2SLC6A4
SCHEMBL6838676 0.83 JAK1 (0.31)
SCHEMBL6833709 0.83 HRH1 (0.36) ALDH1A1KDM4EHPGDHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 SLC6A2 4336/4885SLC6A4 3973/4885SLC6A3 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.